{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T13:35:34Z","timestamp":1776605734541,"version":"3.51.2"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.josat.2023.209157","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T21:16:02Z","timestamp":1693343762000},"page":"209157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["What can we learn from COVID-19 to improve opioid treatment? Expert providers respond"],"prefix":"10.1016","volume":"154","author":[{"given":"Lesley M.","family":"Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne C.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tenie","family":"Khachikian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Serrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinfei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erick G.","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.josat.2023.209157_bb0005","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1080\/00952990.2021.1979991","article-title":"The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era","volume":"47","author":"Amram","year":"2021","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"4","key":"10.1016\/j.josat.2023.209157_bb0010","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/00952990.2021.1903023","article-title":"Common themes in early state policy responses to substance use disorder treatment during COVID-19","volume":"47","author":"Andraka-Christou","year":"2021","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2023.209157_bb0015","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","article-title":"Management of opioid use disorder in the USA: Present status and future directions","volume":"393","author":"Blanco","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.josat.2023.209157_bb0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41398-020-0847-1","article-title":"America\u2019s opioid crisis: The need for an integrated public health approach","volume":"10","author":"Blanco","year":"2020","journal-title":"Translational Psychiatry"},{"issue":"6","key":"10.1016\/j.josat.2023.209157_bb0025","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1097\/ADM.0000000000000744","article-title":"Telehealth capability among substance use disorder treatment facilities in counties with high versus low COVID-19 social distancing","volume":"14","author":"Cantor","year":"2020","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2023.209157_bb0030","series-title":"Constructing grounded theory","author":"Charmaz","year":"2014"},{"key":"10.1016\/j.josat.2023.209157_bb0035","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3389\/fpsyt.2020.00767","article-title":"COVID-19: The hidden impact on mental health and drug addiction","volume":"11","author":"Chiappini","year":"2020","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.josat.2023.209157_bb0040","author":"Chu"},{"issue":"1","key":"10.1016\/j.josat.2023.209157_bb0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","volume":"20","author":"Cohen","year":"1960","journal-title":"Educational and Psychological Measurement"},{"key":"10.1016\/j.josat.2023.209157_bb0050","author":"County of Los Angeles Public Health"},{"key":"10.1016\/j.josat.2023.209157_bb0055","author":"County of Los Angeles Public Health"},{"key":"10.1016\/j.josat.2023.209157_bb0065","author":"COVID OTP Billing Guidance"},{"issue":"7","key":"10.1016\/j.josat.2023.209157_bb0070","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1001\/jama.288.7.850","article-title":"Changes in methadone treatment practices: Results from a national panel study, 1988\u20132000","volume":"288","author":"D\u2019Aunno","year":"2002","journal-title":"JAMA"},{"issue":"Fall 2020","key":"10.1016\/j.josat.2023.209157_bb0075","first-page":"32","article-title":"COVID-19: The resurrection of resilience and self-care for the addiction professional","author":"Dombrowski","year":"2020","journal-title":"Advances in Addiction & Recovery"},{"key":"10.1016\/j.josat.2023.209157_bb0080","author":"Dunlap"},{"key":"10.1016\/j.josat.2023.209157_bb0085","series-title":"Toward a general theory of expertise: Prospects and limits","author":"Ericsson","year":"1996"},{"key":"10.1016\/j.josat.2023.209157_bb0090","first-page":"7","article-title":"Expertise in social work practice: An exploratory study","author":"Fook","year":"1996","journal-title":"Canadian Social Work Review\/Revue Canadienne De Service Social"},{"issue":"3","key":"10.1016\/j.josat.2023.209157_bb0095","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/oxfordjournals.bjsw.a011220","article-title":"Towards a theory of social work expertise","volume":"27","author":"Fook","year":"1997","journal-title":"The British Journal of Social Work"},{"issue":"10","key":"10.1016\/j.josat.2023.209157_bb0100","doi-asserted-by":"crossref","first-page":"e2236298","DOI":"10.1001\/jamanetworkopen.2022.36298","article-title":"Use of and retention on video, telephone, and in-person buprenorphine treatment for opioid use disorder during the COVID-19 pandemic","volume":"5","author":"Frost","year":"2022","journal-title":"JAMA Network Open"},{"issue":"2\u20133","key":"10.1016\/j.josat.2023.209157_bb0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.healthpol.2010.05.013","article-title":"Evidence-based practices in addiction treatment: Review and recommendations for public policy","volume":"97","author":"Glasner-Edwards","year":"2010","journal-title":"Health Policy"},{"issue":"4","key":"10.1016\/j.josat.2023.209157_bb0110","article-title":"COVID-19 impact on behavioral health service systems that treat youth populations with substance use disorders","volume":"2","author":"Gonzales-Castaneda","year":"2021","journal-title":"Journal of Pharmacy and Drug Innovations"},{"issue":"10","key":"10.1016\/j.josat.2023.209157_bb0115","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1007\/s11606-020-06081-w","article-title":"Racial and ethnic disparities in population-level COVID-19 mortality","volume":"35","author":"Gross","year":"2020","journal-title":"Journal of General Internal Medicine"},{"issue":"4","key":"10.1016\/j.josat.2023.209157_bb0195","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10488-015-0662-9","article-title":"Expected impact of health care reform on the organization and service delivery of publicly funded addiction health services","volume":"44","author":"Guerrero","year":"2015","journal-title":"Administration and Policy in Mental Health and Mental Health Services Research"},{"key":"10.1016\/j.josat.2023.209157_bb9005","doi-asserted-by":"crossref","DOI":"10.1186\/s13012-016-0438-y","article-title":"Identifying and ranking implicit leadership strategies to promote evidence-based practice implementation in addiction health services","author":"Guerrero","year":"2015","journal-title":"Implementation Science"},{"key":"10.1016\/j.josat.2023.209157_bb0200","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jsat.2015.08.002","article-title":"Improving Coordination of Addiction Health Services Organizations with Mental Health and Public Health Services","volume":"60","author":"Guerrero","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2023.209157_bb0120","doi-asserted-by":"crossref","first-page":"e2252381","DOI":"10.1001\/jamanetworkopen.2022.52381","article-title":"Telemedicine use and quality of opioid use disorder treatment in the US during the COVID-19 pandemic","volume":"6","author":"Hailu","year":"2023","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2023.209157_bb0125","series-title":"Welfare reform in America","article-title":"The moral construction of poverty","volume":"Vol. 144","author":"Handler","year":"1991"},{"key":"10.1016\/j.josat.2023.209157_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108223","article-title":"Re-thinking patient stability for methadone in opioid treatment programs during a global pandemic: Provider perspectives","volume":"124","author":"Hatch-Maillette","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209157_bb0135","article-title":"Impact of the coronavirus pandemic on substance use disorder treatment: Findings from a survey of specialty providers in California","volume":"15","author":"Henretty","year":"2021","journal-title":"Substance Abuse: Research and Treatment"},{"key":"10.1016\/j.josat.2023.209157_bb0140","author":"Holliday"},{"issue":"9","key":"10.1016\/j.josat.2023.209157_bb0145","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"5","author":"Hsieh","year":"2005","journal-title":"Qualitative Health Research"},{"key":"10.1016\/j.josat.2023.209157_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108163","article-title":"The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19","volume":"120","author":"Hughto","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209157_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108288","article-title":"Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study","volume":"124","author":"Hunter","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209157_bb0160","series-title":"Research methods for clinical and health psychology","first-page":"56","article-title":"Content and thematic analysis","author":"Joffe","year":"2004"},{"issue":"8","key":"10.1016\/j.josat.2023.209157_bb0165","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","article-title":"National and state treatment need and capacity for opioid agonist medication-assisted treatment","volume":"105","author":"Jones","year":"2015","journal-title":"American Journal of Public Health"},{"issue":"3","key":"10.1016\/j.josat.2023.209157_bb0170","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jsat.2005.11.004","article-title":"Comparative analysis of state requirements for the training of substance abuse and mental health counselors","volume":"30","author":"Kerwin","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2023.209157_bb0175","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13722-021-00275-1","article-title":"Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: A scoping review","volume":"16","author":"Krawczyk","year":"2021","journal-title":"Addiction Science & Clinical Practice"},{"issue":"1","key":"10.1016\/j.josat.2023.209157_bb0180","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.josat.2023.209157_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108544","article-title":"The impact of COVID-19 on substance use disorder treatment in California: Service providers\u2019 perspectives","volume":"133","author":"Lin","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209157_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109100","article-title":"Treatment provider perceptions of take-home methadone regulation before and during COVID-19","volume":"228","author":"Madden","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209157_bb9000","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108399","article-title":"Gender disparities in access and retention in outpatient methadone treatment for opioid use disorder in low-income urban communities","volume":"127","author":"Marsh","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209157_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108214","article-title":"Addressing racial & socioeconomic disparities in access to medications for opioid use disorder amid COVID-19","volume":"122","author":"Nguemeni Tiako","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.josat.2023.209157_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J010v44n04_01","article-title":"Applying a theory of expertise in health social work administration and practice in Australia","volume":"44","author":"Nilsson","year":"2007","journal-title":"Social Work in Health Care"},{"key":"10.1016\/j.josat.2023.209157_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108255","article-title":"Impacts of COVID-19 on residential treatment programs for substance use disorder","volume":"123","author":"Pagano","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"6","key":"10.1016\/j.josat.2023.209157_bb0220","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1111\/j.1475-6773.2008.00870.x","article-title":"Dosage patterns in methadone treatment: Results from a national survey, 1988\u20132005","volume":"43","author":"Pollack","year":"2008","journal-title":"Health Services Research"},{"key":"10.1016\/j.josat.2023.209157_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103537","article-title":"Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey","volume":"101","author":"Saloner","year":"2022","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2023.209157_bb0230","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000685","article-title":"Innovation during COVID-19: Improving addiction treatment access","author":"Samuels","year":"2020","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2023.209157_bb2012","series-title":"Dedoose Version 9.0.21, web application for managing, analyzing, and presenting qualitative and mixed method research data (2021)","year":"2021"},{"key":"10.1016\/j.josat.2023.209157_bb0235","series-title":"Basics of qualitative research: Techniques and procedures for developing grounded theory","author":"Strauss","year":"2015"},{"key":"10.1016\/j.josat.2023.209157_bb0240","author":"Substance Abuse and Mental Health Services Administration"},{"issue":"1","key":"10.1016\/j.josat.2023.209157_bb0250","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/08897077.2022.2060438","article-title":"\u201cThe idea is to help people achieve greater success and liberty\u201d: A qualitative study of expanded methadone take-home access in opioid use disorder treatment","volume":"43","author":"Suen","year":"2022","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2023.209157_bb0255","author":"Suen"},{"key":"10.1016\/j.josat.2023.209157_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108514","article-title":"Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms","volume":"132","author":"Treitler","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209157_bb0265","author":"U.S. Department of Health and Human Services"},{"key":"10.1016\/j.josat.2023.209157_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108385","article-title":"Research on substance use disorders during the COVID-19 pandemic","volume":"129","author":"Volkow","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.josat.2023.209157_bb0275","doi-asserted-by":"crossref","first-page":"e1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Network Open"},{"issue":"3","key":"10.1016\/j.josat.2023.209157_bb0280","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/ADM.0b013e3182584772","article-title":"Methadone dose, take home status, and hospital admission among methadone maintenance patients","volume":"6","author":"Walley","year":"2012","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2023.209157_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108272","article-title":"Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic","volume":"124","author":"Wang","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2023.209157_bb0290","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41380-020-00880-7","article-title":"COVID-19 risk and outcomes in patients with substance use disorders: Analyses from electronic health records in the United States","volume":"26","author":"Wang","year":"2021","journal-title":"Molecular Psychiatry"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:39:55Z","timestamp":1762652395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923002084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":59,"alternative-id":["S2949875923002084"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209157","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What can we learn from COVID-19 to improve opioid treatment? Expert providers respond","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209157"}}